Strong inference, theory testing, and the neuroanatomy of schizophrenia

Archives of General Psychiatry

Volumn 50, Issue 10, 1993, Pages 825-831

  Carpenter Jr , William T ^a   Buchanan, Robert W ^a   Kirkpatrick, Brian ^a   Tamminga, Carol ^a   Wood, Frank ^b  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN METABOLISM; HUMAN; MODEL; NEUROANATOMY; NEUROPSYCHIATRY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOLOGICAL THEORY; SCHIZOPHRENIA;

BRAIN; FRONTAL LOBE; HUMAN; MODELS, GENETIC; MODELS, NEUROLOGICAL; PHENOTYPE; RISK FACTORS; SCHIZOPHRENIA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; SYNDROME;

EID: 0027451140     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1993.01820220081009     Document Type: Article

References (54)

1. Where next with psychiatric illness? Nature. Novvember 10, 1988;336:95-96.
2. Platt JR. Strong inference. Science. 1964;146:347-353.
3. McHugh PR, Slavney PR, eds. The Perspectives of Psychiatry. Baltimore, Md: Johns Hopkins University Press; 1983.
4. Carpenter WT, Strauss JS, Muleh S. Are there pathognomonic symptoms in schizophrenia? Arch Gen Psychiatry. 1973;28:847-852.
5. Boyd J, Pulver AE, Stewart W. The association between the risk for schizophrenia and season of birth: a review of the literature. Schizophr Bull. 1986;12:173-186.
6. Kendler KS. The genetics of schizophrenia and related disorders: a review. In: Dunner EL, Gershon ES, Barrett JF, eds. Relatives at Risk for Mental Disorder. New York, NY: Raven Press; 1988:247-266.
7. McNeil TF. Perinatal influences in the development of schizophrenia: methodology and mechanisms. In: Helmchen H, Henn FA, eds. Biological Perspectives of Schizophrenia. New York, NY: John Wiley & Sons Inc; 1987:125-138.
8. Lewis SW, Owen MJ, Murray RM. Obstetric complications and schizophrenia: methodology and mechanisms. In: Schulz CS, Tamminga CA, eds. Schizophrenia: Scientific Progress. New York, NY: Oxford University Press; 1989:56-68.
9. Lyon M, Barr CE, Cannon TD, Mednick SA, Shore D. Fetal neural development and schizophrenia. Schizophr Bull. 1989;15:149-161.
10. Mednick SA, Machon RA, Huttunen MO, Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry. 1988;45:189-192.
11. Holzman PS. Recent studies of psychophysiology in schizophrenia. Schizophr Bull. 1987;13:49-75.
12. Freedman R, Adler LE, Waldo MC, Pachtman E, Franks RD. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. Biol Psychiatry. 1983;18:537-552.
13. Braff DL, Stone C, Callaway E, Geyer MA, Glick ID, Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 1978;15:339-343.
14. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44:660-669.
15. Buchsbaum M, Haier RJ. Biological homogeneity, symptom heterogeneity and the diagnosis of schizophrenia. Schizophr Bull. 1978;4:473-476.
16. Crow TJ. The two-syndrome concept: origins and current status. Schizophr Bull. 1985;11:471-486.
17. Kraepelin E. Dementia Praecox and Paraphrenia. New York, NY: Robert E Krieger; 1971.
18. Strauss JS, Carpenter WT, Bartko JJ. Towards an understanding of the symptom picture considered characteristic of schizophrenia: its description, precursors and outcome. Schizophr Bull. 1974;11:61-69.
19. Carpenter WT, Heinrichs DW, Wagman AMI. On the heterogeneity of schizophrenia. In: Alpert M, ed. Controversies in Schizophrenia. New York, NY: Guilford Press; 1985:25-37.
20. Tsuang MT, Lyons MJ, Faraone SV. Heterogeneity of schizophrenia: conceptual models and analytic strategies. Br J Psychiatry. 1990;156:17-26.
21. Pogue-Geile MF, Keshavan M. Negative symptomatology in schizophrenia: syndrome and sub-type status. In: Greden JF, Tandon R, eds. Negative Schizophrenic Symptoms: Pathophysiology and Clinical Implications. Washington, DC: American Psychiatric Press; 1991:43-59.
22. Carpenter WT, Buchanan RW. Domains of psychopathology relevant to the study of etiology and treatment of schizophrenia. In: Schulz SC, Tamminga CA, eds. Schizophrenia: Scientific Progress. New York, NY: Oxford University Press; 1989:13-22.
23. Kay SR, Sevy S. Pyramidical model of schizophrenia. Schizophr Bull. 1990;16:537-545.
24. Lenzenweger MF, Dworkin RH, Wethington E. Examining the underlying structure of schizophrenic phenomenology: evidence for a three-process model. Schizophr Bull. 1991;17:515-524.
25. Arndt S, Alliger RJ, Andreasen NC. The distinction of positive and negative symptoms: the failure of the two-dimensional model. Br J Psychiatry. 1991;158:317-322.
26. Barnes TRE, Liddle PF. Evidence for the validity of negative symptoms. Mod Probl Pharmacopsychiatry. 1990;24:43-72.
27. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci. 1986;9:357-381.
28. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990;13:272-276.
29. Cavada C, Goldman-Rakic PS. Posterial parietal cortex in rhesus monkey, I: parcellation of areas based on distinctive limbic and sensory corticocortical connections. J Comp Neurol. 1989;287:393-421.
30. Cavada C, Goldman-Rakic PS. Posterior parietal cortex in rhesus monkey, II: evidence for segregated corticocortical networks linking sensory and limbic areas with the frontal lobe. J Comp Neurol. 1989;287:422-445.
31. Mesulam MM. Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol. 1990;28:597-613.
32. Popper KR. The Logic of Scientific Discovery. New York, NY: Basic Books; 1959.
33. Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry. 1991;148:1474-1481.
34. Kety SS, Rosenthal D, Wender PH, Schulsinger F, Jacobsen B. The biological and adoptive families of adopted individuals who become schizophenic: prevalence of mental illness and other characteristics. In: Wynne LC, Cromwell RL, Matthysse S, eds. The Nature of Schizophrenia. New York, NY: John Wiley & Sons Inc; 1978:25-37.
35. Bleuler E; Zinken J, Trans. Dementia Praecox or the Group of Schizophenias. New York, NY: International Universities Press; 1950.
36. Levin S. Frontal lobe dysfunctions in schizophrenia, II: impairments of psychological and brain functions. J Psychiatr Res. 1984;18:57-72.
37. Goldman-Rakic PS, Selemon LD. New frontiers in basal ganglia research. Trends Neurosci. 1990;13:241-244.
38. Graybiel AM. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 1990;13:244-254.
39. Parent A. Extrinsic connections of the basal ganglia. Trends Neurosci. 1990;13:254-258.
40. Smith AD, Bolam JP. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci. 1990;13:259-265.
41. Carlsson M, Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia: implications for schizophrenia and Parkinson's disease. Trends Neurosci. 1990;13:272-276.
42. Buchsbaum MS. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr Bull. 1990;16:379-389.
43. Bogerts B. Recent advances in the neuropathology of schizophrenia. Schizophr Bull. In press.
44. Zigun JR, Weinberger DR. In vivo studies of brain morphology in schizophrenia. In: Lindenmayer JP, Kay SR, eds. New Biological Vistas on Schizophrenia. New York, NY: Brunner/Mazel Inc; 1992:57-81.
45. Casanova MF, Stevens JR, Kleinman JE. The neuropathology of schizophrenia: old and new findings. In: Lindenmayer JP, Kay SR, eds. New Biological Vistas on Schizophrenia. New York, NY: Brunner/Mazel Inc; 1992:82-109.
46. Carpenter WT, Heinrichs DW, Wagman AMI. Deficit and non-deficit forms of schizophrenia: the concept. Am J Psychiatry. 1988;145:578-583.
47. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT. The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res. 1989;30:119-123.
48. Buchanan RW, Kirkpatrick B, Heinrichs DW, Carpenter WT. Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry. 1990;147:290-294.
49. Thaker GK, Kirkpatrick B, Buchanan RW, Ellsberry R, Lahti A, Tamminga C. Oculomotor abnormalities and their clinical correlates in schizophrenia. Psychophamacol Bull. 1990;25:491-497.
50. Kirkpatrick B, Buchanan RW. Anhedonia and the deficit syndrome of schizophrenia. Psychiatry Res. 1990;31:25-30.
51. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Carpenter WT, Chase TN. Limbic system abnormalities identified in schizophrenia using PET/FDG: and neocortical alterations with deficit syndrome. Arch Gen Psychiatry. 1992;49:522-530.
52. Buchanan RW, Breier A, Kirkpatrick B, Elkashef A, Munson RC, Gellad F, Carpenter WT. Structural abnormalities in deficit vs. non-deficit schizophrenia. Am J Psychiatry. 1993;150:59-65.
53. Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RSJ. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry. 1992;160:179-186.
54. Carpenter WT. Psychopathology and common sense: where we went wrong with negative symptoms. Biol Psychiatry. 1991;29:735-737.